CDC Advisers Recommend Making RSV Vaccines Available to Younger Age Group

Respiratory syncytial virus vaccines are currently available for adults aged 60 and up.

A colorized scanning electron micrograph shows human respiratory syncytial virus (RSV) virions shedding from human lung epithelial cells. NIAID via The Epoch Times

Advisers to the Centers for Disease Control and Prevention on April 16 recommended that the agency expand the availability of vaccines against the respiratory syncytial virus, or RSV.

Adults with at least one risk factor for RSV should be able to receive a vaccine, the Advisory Committee on Immunization Practices said in a 14–0 vote, with one member abstaining.